Nighttime Severe Cold And Flu Maximum Strength Mini Softgels
NDC 83059-0095
Product Information
Nighttime Severe Cold And Flu Maximum Strength Mini Softgels is a OTC MONOGRAPH DRUG-approved product labeled by Shield Pharmaceuticals Corp. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a green product. This product entry covers the primary NDC 83059-0095 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
SNM
Code Structure Chart
Product Details
What is NDC 83059-0095?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
- DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH)
- DEXTROMETHORPHAN (UNII: 7355X3ROTS) (Active Moiety)
- DOXYLAMINE SUCCINATE (UNII: V9BI9B5YI2)
- DOXYLAMINE (UNII: 95QB77JKPL) (Active Moiety)
- PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ)
- PHENYLEPHRINE (UNII: 1WS297W6MV) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- POVIDONE (UNII: FZ989GH94E)
- SORBITOL SOLUTION (UNII: 8KW3E207O2)
- WATER (UNII: 059QF0KO0R)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- GELATIN (UNII: 2G86QN327L)
- GLYCERIN (UNII: PDC6A3C0OX)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
* Please review the full disclaimer at the bottom of this page.